An author says they are offering services to write new books for what they describe as the “Ozempic generation,” citing growing use of weight-loss medication. Both reports present the same central claim: the writer believes demand is increasing and that there is a gap in the market for book content tailored to people taking these medicines. The articles frame the initiative as a publishing and writing proposal rather than a policy development or clinical announcement. They do not present detailed evidence on market size, publication plans, or specific book titles. Instead, they focus on the author’s intent to create material for an audience shaped by medication-assisted weight loss. The reports also do not attribute the remarks to official bodies or provide corroborating statistics about medication uptake. Overall, the coverage aligns on the premise that the author is seeking to write books for readers using weight-loss drugs, driven by perceived changes in consumer needs.